The Emily Whitehead story

Cell and gene therapies are revolutionizing healthcare by saving lives — like Emily’s. What made that possible? Passion and dedication from patients, families, scientists, and doctors. What we need now is more standardized and reproducible processes for making these therapies. That’s where Cytiva comes in.

Make AAV your way.

Tips for viral vector production

We bring together insights to help you develop a scalable and cost-efficient manufacturing process.
gene therapy icon

How to optimize and scale up AAV production

Leaders from academia and industry engage on topics ranging from technology to ways of working.
Apheresis collection

Apheresis: how to reduce variability

Learn best practices for apheresis collection and obtaining enriched mononuclear cell (MNC) product.
The vein-to-vein autologous cell therapy workflow

Cryogenic shipping: mitigating risk

How to alleviate risk exposure with future supply chain disruptions and scaling to meet demand.